Gaetan Leblay

Gaetan Leblay

Johnson & Johnson Co. - New Jersey / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5330067
-
person_outline Gaetan Leblay's MOST POPULAR ARTICLES
1-) Impact of subsequent metastases on costs and medical resource use for prostate cancer patients initially diagnosed with localized diseaseTT Li, ND Shore, M Mehra, MB Todd, R Saadi, G Leblay, J Aggarwal, ...Cancer 123 (18), 3591-3601, 2017242017
2-) Medical resource use and costs from subsequent metastases in patients with prostate cancer initially diagnosed with locoregional disease.T Li, ND Shore, M Mehra, MB Todd, R Saadi, G Leblay, RI Griffiths, ...Journal of Clinical Oncology 34 (15_suppl), e16564-e16564, 20162016
3-) THE IMPACT OF SUBSEQUENT METASTASES ON SURVIVAL AND MEDICAL COSTS IN PROSTATE CANCER PATIENTS: MP04-20N Shore, T Li, M Mehra, M Todd, R Saadi, G Leblay, R GriffithsJournal of Urology 195 (4), e36, 20162016
4-) The impact of subsequent metastasis on medical costs in Medicare patients with prostate cancer.T Li, ND Shore, M Mehra, MB Todd, R Saadi, G Leblay, R GriffithsJournal of Clinical Oncology 34 (2_suppl), 81-81, 20162016
5-) The impact of subsequent metastasis on survival in Medicare patients with prostate cancer.T Li, ND Shore, M Mehra, MB Todd, R Saadi, G Leblay, R GriffithsJournal of Clinical Oncology 34 (2_suppl), 94-94, 20162016